Circadian dysregulation of clock genes: Clues to rapid treatments in major depressive disorder

Molecular Psychiatry

Volumn 20, Issue 1, 2015, Pages 48-55

  Bunney, B G ^a   Li, J Z ^b   Walsh, D M ^a   Stein, R ^a   Vawter, M P ^a   Cartagena, P ^a   Barchas, J D ^a   Schatzberg, A F ^c   Myers, R M ^d   Watson, S J ^e   Akil, H ^e   Bunney, W E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY   (United States)

^d HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTIDEPRESSANT AGENT; CORTICOSTEROID; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; MELATONIN; AMINO ACID RECEPTOR BLOCKING AGENT; TRANSCRIPTION FACTOR CLOCK;

ANTERIOR CINGULATE; BRAIN REGION; BRAIN TISSUE; CIRCADIAN RHYTHM; CORTICOSTEROID RELEASE; DEPRESSION; DISEASE ASSOCIATION; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HORMONE RELEASE; HUMAN; HYPOPHYSIS; IMAGE ANALYSIS; LOW DRUG DOSE; MAJOR DEPRESSION; MICROARRAY ANALYSIS; MOLECULAR CLOCK; MOOD; MOOD DISORDER; NERVE CELL CULTURE; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; RELAPSE; REVIEW; SLEEP; SLEEP DEPRIVATION; THERMOREGULATION; ANIMAL; CINGULATE GYRUS; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; GENETICS; METABOLISM; SLEEP DISORDER;

ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONOBIOLOGY DISORDERS; CLOCK PROTEINS; DEPRESSIVE DISORDER, MAJOR; EXCITATORY AMINO ACID ANTAGONISTS; GYRUS CINGULI; HUMANS; KETAMINE; SLEEP DEPRIVATION;

EID: 84922259014     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.138     Document Type: Review

References (132)

1. Masri S, Sassone-Corsi P. The circadian clock: a framework linking metabolism, epigenetics and neuronal function. Nat Rev Neurosci 2013; 14: 69-75.
2. Edgar N, McClung CA. Major depressive disorder: a loss of circadian synchrony? Bioessays 2013; 35: 940-944.
3. Hasler BP, Buysse DJ, Kupfer DJ, Germain A. Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression. Psychiatry Res 2010; 178: 205-207.
4. Bunney BG, Bunney WE. Rapid-acting antidepressant strategies: mechanisms of action. Int J Neuropsychopharmacol 2012; 15: 695-713.
5. Insel TR, Wang PS. The STAR∗D trial: revealing the need for better treatments. Psychiatr Serv 2009; 60: 1466-1467.
6. Rush AJ, Trivedi M, Fava M. Depression, IV: STAR∗D treatment trial for depression. Am J Psychiatry 2003; 160: 237.
7. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351-354.
8. Mathews DC, Zarate CA Jr. Current status of ketamine and related compounds for depression. J Clin Psychiatry 2013; 74: 516-517.
9. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147: 14-21.
10. Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev 2007; 11: 509-522.
11. Zunszain PA, Horowitz MA, Cattaneo A, Lupi MM, Pariante CM. Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Mol Psychiatry 2013; 18: 1236-1241.
12. Dijk DJ, Duffy JF, Silva EJ, Shanahan TL, Boivin DB, Czeisler CA. Amplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humans. PLoS One 2012; 7: e30037.
13. Fisher SP, Foster RG, Peirson SN. The circadian control of sleep. Handb Exp Pharmacol 2013; 217: 157-183.
14. Franken P, Dijk DJ. Circadian clock genes and sleep homeostasis. Eur J Neurosci 2009; 29: 1820-1829.
15. Borbely AA, Tobler I. Manifestations and functional implications of sleep homeostasis. Handb Clin Neurol 2011; 98: 205-213.
16. Mendlewicz J. Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. World J Biol Psychiatry 2009; 10: 269-275.
17. Ohayon MM. Insomnia: a ticking clock for depression? J Psychiatr Res 2007; 41: 893-894.
18. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008; 23: 571-585.
19. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008; 10: 473-481.
20. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146: 105-114.
21. Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 2012; 73: e1160-e1167.
22. Kupfer DJ, Foster FG, Reich L, Thompson SK, Weiss B. EEG sleep changes as predictors in depression. Am J Psychiatry 1976; 133: 622-626.
23. Troxel WM, Kupfer DJ, Reynolds CF 3rd, Frank E, Thase ME, Miewald JM et al. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapypharmacotherapy combinations. J Clin Psychiatry 2012; 73: 478-485.
24. Buysse DJ, Monk TH, Kupfer DJ, Frank E, Stapf D. Circadian patterns of unintended sleep episodes during a constant routine in remitted depressed patients. J Psychiatr Res 1995; 29: 407-416.
25. Murray G. Diurnal mood variation in depression: a signal of disturbed circadian function? J Affect Disord 2007; 102: 47-53.
26. Wirz-Justice A. Diurnal variation of depressive symptoms. Dialogues Clin Neurosci 2008; 10: 337-343.
27. Saini C, Morf J, Stratmann M, Gos P, Schibler U. Simulated body temperature rhythms reveal the phase-shifting behavior and plasticity of mammalian circadian oscillators. Genes Dev 2012; 26: 567-580.
28. Avery DH, Shah SH, Eder DN, Wildschiodtz G. Nocturnal sweating and temperature in depression. Acta Psychiatr Scand 1999; 100: 295-301.
29. Elsenga S, Van den Hoofdakker RH. Body core temperature and depression during total sleep deprivation in depressives. Biol Psychiatry 1988; 24: 531-540.
30. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry 1988; 145: 1133-1137.
31. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 2006; 60: 275-281.
32. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23: 477-501.
33. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB. CSF corticotropinreleasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987; 144: 873-877.
34. Bunney WE Jr., Fawcett JA, Davis JM, Gifford S. Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry 1969; 21: 138-150.
35. Carpenter WT Jr., Bunney WE Jr. Adrenal cortical activity in depressive illness. Am J Psychiatry 1971; 128: 31-40.
36. Scharnholz B, Lederbogen F, Feuerhack A, Bach A, Kopf D, Frankhauser P et al. Does night-time cortisol excretion normalize in the long-term course of depression? Pharmacopsychiatry 2010; 43: 161-165.
37. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66: 617-626.
38. Lewy AJ. Depressive disorders may more commonly be related to circadian phase delays rather than advances: time will tell. Sleep Med 2010; 11: 117-118.
39. Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depressiona potential biomarker? J Psychiatr Res 2010; 44: 69-74.
40. Khaleghipour S, Masjedi M, Ahade H, Enayate M, Pasha G, Nadery F et al. Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study. Sao Paulo Med J 2012; 130: 167-172.
41. Robillard R, Naismith SL, Rogers NL, Scott EM, Ip TK, Hermens DF et al. Sleepwake cycle and melatonin rhythms in adolescents and young adults with mood disorders: Comparison of unipolar and bipolar phenotypes. Eur Psychiatry 2013; 28: 412-416.
42. Lamont EW, Coutu DL, Cermakian N, Boivin DB. Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Relat Sci 2010; 47: 27-35.
43. Zanini M, Castro J, Coelho FM, Bittencourt L, Bressan RA, Tufik S et al. Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations? Neurosci Biobehav Rev 2013; 37: 2631-2637.
44. Gonzalez R, Tamminga CA, Tohen M, Suppes T. The relationship between affective state and the rhythmicity of activity in bipolar disorder. J Clin Psychiatry 2014; 75: e317-e322.
45. Morin LP. Neuroanatomy of the extended circadian rhythm system. Exp Neurol 2013; 243: 4-20.
46. McCarthy MJ, Welsh DK. Cellular circadian clocks in mood disorders. J Biol Rhythms 2012; 27: 339-352.
47. Salomon RM, Cowan RL. Oscillatory serotonin function in depression. Synapse 2013; 67: 801-820.
48. van Oosterhout F, Lucassen EA, Houben T, vanderLeest HT, Antle MC, Meijer JH. Amplitude of the SCN clock enhanced by the behavioral activity rhythm. PLoS One 2012; 7: e39693.
49. Mistlberger RE, Antle MC. Entrainment of circadian clocks in mammals by arousal and food. Essays Biochem 2011; 49: 119-136.
50. Sahar S, Sassone-Corsi P. The epigenetic language of circadian clocks. Handb Exp Pharmacol 2013; 217: 29-44.
51. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B et al. Interacting molecular loops in the mammalian circadian clock. Science 2000; 288: 1013-1019.
52. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 2012; 35: 445-462.
53. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol 2014; 24: 90-99.
54. Wu YH, Fischer DF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van Heijningen C et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the master clock. FASEB J 2006; 20: 1874-1876.
55. Ackermann K, Dehghani F, Bux R, Kauert G, Stehle JH. Day-night expression patterns of clock genes in the human pineal gland. J Pineal Res 2007; 43: 185-194.
56. Wunderer F, Kuhne S, Jilg A, Ackermann K, Sebesteny T, Maronde E et al. Clock gene expression in the human pituitary gland. Endocrinology 2013; 154: 2046-2057.
57. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012; 7: e35367.
58. Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci USA 2013; 110: 9950-9955.
59. Dunlap JC. Molecular bases for circadian clocks. Cell 1999; 96: 271-290.
60. Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS spectrums 2008; 13: 663-681.
61. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660.
62. Gotlib IH, Sivers H, Gabrieli JD, Whitfield-Gabrieli S, Goldin P, Minor KL et al. Subgenual anterior cingulate activation to valenced emotional stimuli in major depression. Neuroreport 2005; 16: 1731-1734.
63. Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CA Jr. et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 2009; 65: 289-295.
64. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158: 405-415.
65. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011; 36: 183-206.
66. Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci 2013; 25: 126-133.
67. Fu CH, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 2013; 52: 75-83.
68. Rentzsch J, Adli M, Wiethoff K, Gomez-Carrillo de Castro A, Gallinat J. Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodes. Eur Arch Psychiatry Clin Neurosci 2013; 264: 213-223.
69. Milak MS, Parsey RV, Lee L, Oquendo MA, Olvet DM, Eipper F et al. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res 2009; 173: 63-70.
70. Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N et al. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. Bipolar Disord 2013; 16: 119-128.
71. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149: 538-543.
72. McCormick LM, Boles Ponto LL, Pierson RK, Johnson HJ, Magnotta V, Brumm MC. Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy. J ECT 2007; 23: 265-273.
73. McCormick LM, Yamada T, Yeh M, Brumm MC, Thatcher RW. Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression. J Psychiatr Res 2009; 43: 553-560.
74. Langguth B, Wiegand R, Kharraz A, Landgrebe M, Marienhagen J, Frick U et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol Lett 2007; 28: 633-638.
75. Hernandez-Ribas R, Deus J, Pujol J, Segalas C, Vallejo J, Menchon JM et al. Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression. Brain Stimulation 2013; 6: 54-61.
76. Broadway JM, Holtzheimer PE, Hilimire MR, Parks NA, Devylder JE, Mayberg HS et al. Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology 2012; 37: 1764-1772.
77. Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS et al. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 2009; 34: 175-180.
78. Li JZ. Circadian rhythms and mood: opportunities for multi-level analyses in genomics and neuroscience. Bioessays 2014; 36: 305-315.
79. Jiang WG, Li SX, Zhou SJ, Sun Y, Shi J, Lu L. Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus. Brain Res 2011; 1399: 25-32.
80. Jiang WG, Li SX, Liu JF, Sun Y, Zhou SJ, Zhu WL et al. Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress. Psychopharmacology (Berl) 2013; 227: 79-92.
81. Kinoshita C, Miyazaki K, Ishida N. Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3beta phosphorylation in the central clock. Neuroreport 2012; 23: 98-102.
82. Landgraf D, McCarthy MJ, Welsh DK. The role of the circadian clock in animal models of mood disorders. Behav Neurosci 2014; 128: 344-359.
83. Wongchitrat P, Mukda S, Phansuwan-Pujito P, Govitrapong P. Effect of amphetamine on the clock gene expression in rat striatum. Neurosci Lett 2013; 542: 126-130.
84. Masubuchi S, Honma S, Abe H, Nakamura W, Honma K. Circadian activity rhythm in methamphetamine-treated Clock mutant mice. Eur J Neurosci 2001; 14: 1177-1180.
85. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 2009; 66: 298-301.
86. Bunney BG, Bunney WE. Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiatry 2013; 73: 1164-1171.
87. Benedetti F, Colombo C. Sleep deprivation in mood disorders. Neuropsychobiology 2011; 64: 141-151.
88. Wirz-Justice A, Benedetti F., Terman M. Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy. Karger: Basel, 2009.
89. Wisor JP, O'Hara BF, Terao A, Selby CP, Kilduff TS, Sancar A et al. A role for cryptochromes in sleep regulation. BMC Neurosci 2002; 3: 20.
90. Wisor JP, Pasumarthi RK, Gerashchenko D, Thompson CL, Pathak S, Sancar A et al. Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains. J Neurosci 2008; 28: 7193-7201.
91. Mongrain V, La Spada F, Curie T, Franken P. Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS One 2011; 6: e26622.
92. Thompson CL, Wisor JP, Lee CK, Pathak SD, Gerashchenko D, Smith KA et al. Molecular and anatomical signatures of sleep deprivation in the mouse brain. Front Neurosci 2010; 4: 165.
93. Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C et al. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci USA 2007; 104: 20090-20095.
94. Benedetti F, Dallaspezia S, Lorenzi C, Pirovano A, Radaelli D, Locatelli C et al. Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. J Affect Disord 2012; 136: 514-519.
95. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004; 355: 37-40.
96. Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 2004; 368: 123-126.
97. Beurel E, Song L, Jope RS. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 2011; 16: 1068-1070.
98. Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R et al. Protein levels of beta-catenin and activation state of glycogen synthase kinase-3beta in major depression. A study with postmortem prefrontal cortex. J Affect Disord 2012; 136: 185-188.
99. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959-964.
100. Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res 2000; 885: 303-321.
101. Mizoro Y, Yamaguchi Y, Kitazawa R, Yamada H, Matsuo M, Fustin JM et al. Activation of AMPA receptors in the suprachiasmatic nucleus phase-shifts the mouse circadian clock in vivo and in vitro. PLoS One 2010; 5: e10951.
102. Cirelli C, Tononi G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J Neurosci 2000; 20: 9187-9194.
103. Chen C, Hardy M, Zhang J, LaHoste GJ, Bazan NG. Altered NMDA receptor trafficking contributes to sleep deprivation-induced hippocampal synaptic and cognitive impairments. Biochem Biophys Res Commun 2006; 340: 435-440.
104. Vecsey CG, Peixoto L, Choi JH, Wimmer M, Jaganath D, Hernandez PJ et al. Genomic analysis of sleep deprivation reveals translational regulation in the hippocampus. Physiol Genomics 2012; 44: 981-991.
105. Cao R, Robinson B, Xu H, Gkogkas C, Khoutorsky A, Alain T et al. Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling. Neuron 2013; 79: 712-724.
106. Moller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA 2013; 110: E1132-E1141.
107. Archer SN, Viola AU, Kyriakopoulou V, von Schantz M, Dijk DJ. Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes. Sleep 2008; 31: 608-617.
108. Ackermann K, Plomp R, Lao O, Middleton B, Revell VL, Skene DJ et al. Effect of sleep deprivation on rhythms of clock gene expression and melatonin in humans. Chronobiol Int 2013; 30: 901-909.
109. Kavcic P, Rojc B, Dolenc-Groselj L, Claustrat B, Fujs K, Poljak M. The impact of sleep deprivation and nighttime light exposure on clock gene expression in humans. Croat Med J 2011; 52: 594-603.
110. Lavebratt C, Sjoholm LK, Soronen P, Paunio T, Vawter MP, Bunney WE et al. CRY2 is associated with depression. PLoS One 2010; 5: e9407.
111. Zarate C Jr., Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 2010; 18: 293-303.
112. DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010; 71: 1605-1611.
113. Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 2011; 14: 1127-1131.
114. Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 2009; 66: 522-526.
115. Zigman D, Blier P. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report. J Clin Psychopharmacol 2013; 33: 270-272.
116. Zarate CA Jr., Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012; 71: 939-946.
117. Harihar C, Dasari P, Srinivas JS. Intramuscular ketamine in acute depression: a report on two cases. Indian J Psychiatry 2013; 55: 186-188.
118. De Gioannis A, De Leo D. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression. Aust N Z J Psychiatry 2014; 48: 686.
119. Papolos DF, Teicher MH, Faedda GL, Murphy P, Mattis S. Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype. J Affect Disord 2013; 147: 431-436.
120. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30.
121. Browne CA, Lucki I. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 2013; 4: 161.
122. Kavalali ET, Monteggia LM. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 2012; 169: 1150-1156.
123. Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One 2011; 6: e23982.
124. Maiese K, Chong ZZ, Shang YC, Wang S. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med 2013; 19: 51-60.
125. Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 2013; 38: 2268-2277.
126. Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 2013; 38: 2789-2799.
127. Cuesta M, Clesse D, Pevet P, Challet E. New light on the serotonergic paradox in the rat circadian system. J Neurochem 2009; 110: 231-243.
128. Furey ML, Drevets WC. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 2006; 63: 1121-1129.
129. Monteggia LM, Kavalali ET. Scopolamine and ketamine: evidence of convergence? Biol Psychiatry 2013; 74: 712-713.
130. Srinivasan V, Singh J, Pandi-Perumal SR, Brown GM, Spence DW, Cardinali DP. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. Adv Ther 2010; 27: 796-813.
131. Katz G, Knobler HY, Laibel Z, Strauss Z, Durst R. Time zone change and major psychiatric morbidity: the results of a 6-year study in Jerusalem. Compr Psychiatry 2002; 43: 37-40.
132. Chen Z, Yoo SH, Takahashi JS. Small molecule modifiers of circadian clocks. Cell Mol Life Sci 2012; 70: 2985-2998.